Bellevue Life Sciences Acquisition (BLAC) Stock Chart & Stock Price History $0.64 -0.05 (-6.67%) As of 08/1/2025 Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock Bellevue Life Sciences Acquisition Stock Price Performance The Bellevue Life Sciences Acquisition (BLAC) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 94.07%, with a year-to-date return of -94.43%. In the past month, the stock has decreased 57.46%, reflecting recent market activity. As of the latest close, Bellevue Life Sciences Acquisition traded at $0.69 with a market cap of $2.78 million and volume of 1.26 million shares. Receive BLAC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Bellevue Life Sciences Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-34.46%1 Month Performance-57.46%3 Month Performance-52.42%Year-To-Date Performance-94.43%1 Year Performance-94.07% BLAC Stock Chart for Saturday, August, 2, 2025 BLAC Chart by TradingView Bellevue Life Sciences Acquisition Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/01/2025$0.87$0.69-20.44%$0.80$0.651.26 million shs$2.78 million07/31/2025$0.94$0.87-8.32%$0.97$0.836.94 million shs$3.50 million07/30/2025$0.94$0.94$1.04$0.91387,491 shs$3.81 million07/29/2025$0.98$0.94-3.72%$1.04$0.91387,491 shs$3.81 million07/28/2025$0.98$0.98$1.06$0.90756,392 shs$3.96 million07/25/2025$1.02$1.02$1.05$1.0274,052 shs$4.12 million07/24/2025$1.06$1.02-3.77%$1.05$1.0274,052 shs$4.12 million07/23/2025$1.06$1.06$1.07$1.01325,374 shs$4.28 million07/22/2025$1.06$1.06$1.07$1.01325,374 shs$4.28 million07/21/2025$1.06$1.06$1.07$1.01325,374 shs$4.28 million Get the Latest News and Ratings for BLAC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bellevue Life Sciences Acquisition and its competitors with MarketBeat's FREE daily newsletter. 07/18/2025$1.18$1.00-15.25%$1.08$1.00131,822 shs$4.04 million07/17/2025$1.18$1.18$1.23$1.17118,519 shs$4.77 million07/16/2025$1.18$1.18$1.23$1.17118,519 shs$4.77 million07/15/2025$1.18$1.18$1.23$1.17118,519 shs$4.77 million07/14/2025$1.18$1.18$1.23$1.17118,519 shs$4.77 million07/11/2025$1.24$1.21-2.42%$1.30$1.17170,451 shs$4.89 million07/10/2025$1.35$1.24-8.15%$1.32$1.141.85 million shs$5.01 million07/09/2025$1.35$1.35$1.43$1.31120,923 shs$5.46 million07/08/2025$1.35$1.35$1.43$1.31120,923 shs$5.46 million07/07/2025$1.35$1.35$1.43$1.31120,923 shs$5.46 million07/04/2025$1.39$1.35-2.88%$1.43$1.31120,923 shs$5.46 million07/03/2025$1.51$1.39-7.95%$1.56$1.3798,033 shs$5.62 million07/02/2025$1.38$1.51+9.42%$1.53$1.34172,627 shs$6.10 million07/01/2025$1.35$1.38+2.22%$1.41$1.3047,886 shs$5.58 million Related Companies BDMD Stock Chart XAIR Stock Chart MHUA Stock Chart DHAI Stock Chart BTCY Stock Chart INBS Stock Chart PAVM Stock Chart LUCY Stock Chart LYRA Stock Chart ICU Stock Chart Receive BLAC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Bellevue Life Sciences Acquisition and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BLAC) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredStrange twist to Bitcoin’s rallyThe #1 crypto to buy today Better than Bitcoin? (top crypto for less than $1) Over the past 15 years, B...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bellevue Life Sciences Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bellevue Life Sciences Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
